Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

75.50
BATS BZX Real-Time Price
As of 1:54pm ET
 -0.07 / -0.09%
Today’s Change
63.76
Today|||52-Week Range
86.27
+5.43%
Year-to-Date
CAR T Stocks in Focus with ASH 2017 Meet: GILD, JUNO & More
Dec 15 / Zacks.com - Paid Partner Content
Gilead (GILD) Posts Updated Data on CAR-T Therapy Yescarta
Dec 11 / Zacks.com - Paid Partner Content
Cancer Space Update: Roche, Pfizer & Regeneron Make Data Presentations
Dec 15 / Zacks.com - Paid Partner Content
Novartis Reports Updated Results from Kymriah's JULIET Study
Dec 11 / Zacks.com - Paid Partner Content
6 Stocks Boosting Earnings and Revenue
Dec 14 / GuruFocus News - Paid Partner Content
Here's Why Bluebird Bio (BLUE) Stock Skyrocketed Today
Dec 11 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: ASH Data in Focus, Gilead to Buy Cell Design Labs
Dec 13 / Zacks.com - Paid Partner Content
Key Feature in Marketks
Dec 11 / TheStreet.com - Paid Partner Content
Juno Reports Additional Data on CAR-T Therapy, Shares Drop
Dec 12 / Zacks.com - Paid Partner Content
Company News For Dec 11, 2017
Dec 11 / Zacks.com - Paid Partner Content
Jim Simons: Pioneer Quant Manager
Dec 12 / GuruFocus News - Paid Partner Content
3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise
Dec 11 / Zacks.com - Paid Partner Content
4 Signs the Bull Market in Stocks Remains Incredibly Strong
Dec 12 / TheStreet.com - Paid Partner Content
Gilead Sciences to Acquire Cell Design Labs for $567 Million
Dec 08 / Zacks.com - Paid Partner Content
Bluebird's Shares Jump on Strong Data for CAR-T Therapy
Dec 12 / Zacks.com - Paid Partner Content
Can Drug/Biotech M&A Rebound Next Year After Bleak 2017?
Dec 06 / Zacks.com - Paid Partner Content